Vistagen
Pharmaceuticals, 343 Allerton Ave, South San Francisco, California, 94080, United States, 11-50 Employees
Phone Number: 16*********
Who is VISTAGEN
Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disord...
Read More
-
Headquarters: 343 Allerton Ave, South San Francisco, California, 94080, United States
-
Date Founded: 1998
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Shawn Singh
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
Vistagen Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Vistagen
Answer: Vistagen's headquarters are located at 343 Allerton Ave, South San Francisco, California, 94080, United States
Answer: Vistagen's phone number is 16*********
Answer: Vistagen's official website is https://vistagen.com
Answer: Vistagen's revenue is $10 Million to $25 Million
Answer: Vistagen's SIC: 2834
Answer: Vistagen has 11-50 employees
Answer: Vistagen is in Pharmaceuticals
Answer: Vistagen contact info: Phone number: 16********* Website: https://vistagen.com
Answer: Vistagen (Nasdaq: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. We are advancing therapeutics with the potential to be faster-acting, with fewer side effects and safety concerns, than those currently available for the treatment of anxiety, depression and multiple CNS disorders. Our pipeline includes six clinical-stage product candidates, including fasedienol (PH94B), itruvone (PH10), PH80, PH15, and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral prodrug of an antagonist of the N-methyl-D-aspartate receptor (NMDAR). Pherines are neuroactive nasal sprays designed with an innovative proposed mechanism of action that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic absorption or direct activity on neurons in the brain. We are passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression, and several other CNS disorders.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month